ונקלקסטה 100 מג טבליות ישראל - עברית - Ministry of Health

ונקלקסטה 100 מג טבליות

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax

ונקלקסטה 50 מג טבליות ישראל - עברית - Ministry of Health

ונקלקסטה 50 מג טבליות

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax

ונקלקסטה 50 מג טבליות ישראל - עברית - Ministry of Health

ונקלקסטה 50 מג טבליות

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax

קלטרה תמיסה ישראל - עברית - Ministry of Health

קלטרה תמיסה

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir

קלטרה תמיסה ישראל - עברית - Ministry of Health

קלטרה תמיסה

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir

אוריליסה 150 מג ישראל - עברית - Ministry of Health

אוריליסה 150 מג

abbvie biopharmaceuticals ltd, israel - elagolix as sodium - טבליות מצופות פילם - elagolix as sodium 150 mg - elagolix

אוריליסה 200 מג ישראל - עברית - Ministry of Health

אוריליסה 200 מג

abbvie biopharmaceuticals ltd, israel - elagolix as sodium - טבליות מצופות פילם - elagolix as sodium 200 mg - elagolix

בוטוקס 100 ישראל - עברית - Ministry of Health

בוטוקס 100

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 100 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

בוטוקס 50 ישראל - עברית - Ministry of Health

בוטוקס 50

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

בוטוקס 200 ישראל - עברית - Ministry of Health

בוטוקס 200

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 200 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less.management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrain